Health care biotech companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 health care biotech companies ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
HUF 281.16T
Countries
5

Market values as of .

All countries
Health Care
Biotech
HUF
Clear filters
Health care biotech companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%HUF 2.09THUF 17,096.08 4.94% up 26% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%HUF 1.28THUF 13,213.23 3.14% down 18% down Switzerland
3Twist BioscienceTWST · Health Care14.4%HUF 2.58THUF 37,884.94 4.07% down 346% up United States
4Kodiak SciencesKOD · Health Care12.4%HUF 2.17THUF 33,228.24 0.09% up 399% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%HUF 3.6THUF 31,578.71 2.88% down 39% up United States
6ImmunityBioIBRX · Health Care11.9%HUF 2.37THUF 2,229.92 1.94% down 232% up United States
7RepligenRGEN · Health Care11.0%HUF 3.69THUF 57,798.13 1.38% down 12% up United States
8ExelixisEXEL · Health Care10.5%HUF 5.45THUF 22,343.36 3.60% down 63% up United States
9CG OncologyCGON · Health Care10.3%HUF 2.48THUF 27,797.68 2.38% up 97% up United States
10Krystal BiotechKRYS · Health Care10.3%HUF 3.18THUF 107,192.47 0.15% up 54% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%HUF 3.46THUF 40,522.16 1.44% down 87% up United States
12VaxcytePCVX · Health Care9.70%HUF 3.14THUF 19,807.97 0.27% down 23% up United States
13ImmunovantIMVT · Health Care8.96%HUF 2.28THUF 11,037.61 1.96% down 46% up United States
14ModernaMRNA · Health Care8.20%HUF 27.37THUF 67,654.60 1.29% up 780% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%HUF 1.54THUF 9,520.45 1.44% down 74% up United States
16Revolution MedicinesRVMD · Health Care6.05%HUF 11.7THUF 54,112.14 0.24% down 129% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%HUF 5.38THUF 53,148.21 3.85% down 17% up United States
18Bio-TechneTECH · Health Care4.90%HUF 3.88THUF 24,675.11 0.07% down 24% up United States
19BiogenBIIB · Health Care3.69%HUF 12.4THUF 83,878.39 1.70% down 49% up United States
20QiagenQGEN · Health Care3.10%HUF 3.48THUF 16,844.92 0.14% up 9% up Netherlands
21AmgenAMGN · Health Care2.33%HUF 80.56THUF 148,939.90 1.14% down 32% up United States
22argenxARGX · Health Care2.25%HUF 20.11THUF 319,737.80 0.08% up 2% up Belgium
23Gilead SciencesGILD · Health Care1.72%HUF 70.11THUF 56,521.95 1.45% down 35% up United States
24BioNTechBNTX · Health Care0.91%HUF 6.85THUF 27,621.19 2.26% down 14% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 339.4 HUF).

Questions and answers

Which health care biotech companies rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 health care biotech companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many health care biotech companies are in this ranking?

24 are ranked by short interest.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by short interest have a combined market value of HUF 281.16T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Health care biotech companies by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.